m+Medelevator.RU
← Поиск публикаций
Science translational medicine · 2026

The orphan receptor GPR84 drives inflammation in Buruli ulcer development.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Foulon Mélanie, G Fraga Alexandra, Robbe-Saule Marie, Tarnaud Florian, Lafont Marianne, Lebon Guillaume, Fevereiro João, Pignon Pascale, Boneca Ivo Gomperts, Fanton D'Andon Martine, Martin Ludovic, Croué Anne, Gouault Nicolas, Sauvager Aurélie, Meunier Etienne, Brodin Priscille, Touami Laurence, Labarrière Nathalie, Ganlonon Line, Adeye Ambroise, Marion Estelle, Dubee Vincent, Pedrosa Jorge, Yeramian Edouard, Marsollier Laurent

Аннотация

Inflammatory responses can be of critical importance in determining both the course and outcome of infectious diseases. Buruli ulcer, a neglected tropical disease caused by Mycobacterium ulcerans (M. ulcerans), has been reported to induce both immunosuppressive and proinflammatory responses in the skin. Here, we found that genetic inactivation of the orphan receptor GPR84 in mice leads to spontaneous healing of ulcerative lesions, recapitulating the rare spontaneous healing observed in human Buruli ulcer. Mechanistically, M. ulcerans infection induced Gpr84 expression through Toll-like receptor 2 engagement, promoting proinflammatory cytokine release through a self-amplifying loop that sustained receptor expression and inflammatory signaling. Moreover, pharmacological inhibition of GPR84 with the antagonist PBI-4050, in combination with antibiotics, accelerated tissue repair in infected GPR84-competent mice, which was associated with attenuation of inflammatory responses. Together, these findings establish GPR84 as a promising target for host-directed therapeutic interventions in Buruli ulcer and its expression as a potential biomarker of lesion activity.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты